论文部分内容阅读
病例:男女各5例,年龄21～60岁。按FAB标准分型:RA7例、RAEB2例、CMML1例。治疗前用药情况:除1例RA和1例CMML患者未进行过任何治疗外,均用过各种药物,效果均不佳。1例RAEB曾用小剂量Ara-C,效果不明显。治疗剂量、方法与疗程:开始为40～60mg/d,分2～3次口服,连服1周如无明显副作用,则加量至
Case: 5 males and 5 females, aged from 21 to 60 years old. According to FAB standard classification: RA7 cases, RAEB2 cases, CMML1 cases. Pre-treatment medication: Except for 1 case of RA and 1 case of CMML patients without any treatment, all kinds of drugs were used, the effect is not good. 1 case of RAEB used a small dose of Ara-C, the effect is not obvious. Therapeutic dose, method and course of treatment: the beginning of 40 ~ 60mg / d, 2 to 3 times orally, even for 1 week without obvious side effects, then add to